Carregant...

A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis

BACKGROUND: Recent evidence demonstrates that high doses of epoetin-alpha (EPO-α) can be administrated at extended intervals, despite its relatively short serum half-life. However, no prospective randomized trials on the effects of extended dosing intervals of EPO-α compared with darbepoetin-alpha (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Res Clin Pract
Autors principals: Na, Ha-Young, Lee, Yong-Kyu, Shin, Sug-Kyun, Yang, Dong-Ho, Cheon, Woong, Park, Jung-Hwan, Lee, Jong-Ho, Song, Jong-Oh, Jo, Young-Il
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714283/
https://ncbi.nlm.nih.gov/pubmed/26885479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.krcp.2014.10.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!